Evidence map›Paper›PMID 37869758›Full record

ArticleFrontiers in pharmacology2023

Corrigendum: Systems pharmacology approach to investigate the mechanism of Kai-Xin-San in Alzheimer's disease.

Yunxia Luo, Dongli Li, Yanfang Liao, Chuipu Cai, Qihui Wu, Hanzhong Ke, Xinning Liu, Huilin Li, Honghai Hong, Yumin Xu and 3 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Efficacy and possible mechanism ofFrontiers in pharmacology · 2026
    Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Yunxia Luo *Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Dongli Li *Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yanfang Liao *Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Chuipu CaiScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Qihui WuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Hanzhong KeDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, United States.
Xinning LiuScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Huilin LiDepartment of Endocrinology, Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, China.
Honghai HongDepartment of Clinical Laboratory, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Yumin XuDepartment of Encephalopathy First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
Qi WangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jiansong FangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Shuhuan FangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CNDana-Farber Cancer Institute · USFirst Affiliated Hospital of Henan University · CNThird Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar.2020.00381.].

Indexed as

Alzheimer’s diseasecholinergic systemKai-Xin-Sanneuroinflammationsystems pharmacology

Identifiers

PMID37869758
PMCPMC10588629
OpenAlexW4387407269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.